Clinical Trials Browser

Phase 2 × Salivary Gland Neoplasms × Nivolumab × Clear all

NCT03172624 2025-12-18

Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer

Phase 2 Completed

64 enrolled 9 charts

Salivary Gland Neoplasms

NCT03146650 2024-01-18

Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer

Phase 2 Unknown

25 enrolled 14 charts

Salivary Gland Neoplasms

NCT03132038 2022-01-11

NISCAHN

Phase 2 Completed

Neoplasm Metastasis, Recurrence, Salivary Gland Neoplasms